drugset / Trial / NCT00035841
Phase 2 Study of TLK286 in Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of TLK286 in treatment of metastatic breast cancer.
Timeline
- Start
- 2002-04
- Primary completion
- 2004-07
- Completion
- 2004-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | canfosfamide | Small molecule | — | — |